You are browsing the Hong Kong website, Regulated by Hong Kong SFC (CE number: BJA907). Investment is risky and you must be cautious when entering the market.
格隆匯公吿精選(港股)︱出門問問(02438.HK):出門問問全線AI產品融合DeepSeek
格隆匯 02-10 23:07

【今日焦點】

出門問問(02438.HK):出門問問全線AI產品融合DeepSeek

出門問問(02438.HK)宣佈,於2025年2月,公司與深度求索(DeepSeek)最新推理大模型DeepSeek-R1深度適配,並將其先進能力融於公司全線AI產品中,旨在為用户帶來更智能、更便捷的產品體驗。

公司聯合華為雲上線基於昇騰雲服務的DeepSeek-R1服務,將為用户帶來全新的智能體驗。華為雲昇騰雲服務的強大算力與DeepSeek的先進模型能力,將為公司包括「元創島」、「奇妙問」、「奇妙元」(海外版LivGen)、「魔音工坊」(海外版DupDub)在內的多款產品,注入新的活力。

【財報業績】

青島銀行(03866.HK)2024年淨利潤42.64億元 同比增長20.16%

好孩子國際(01086.HK)盈喜:預計年度純利約3.25億港元-3.75億港元

沛嘉醫療-B(09996.HK)2024年度收入約6.1億元-6.3億元 同比增長約38.3%-42.8%

【運營數據】

東風集團股份(00489.HK):1月累計汽車銷量為11.68萬輛

裕元集團(00551.HK):1月綜合經營收益淨額8.05億美元 同比增加9.3%

綠色動力環保(01330.HK)2024年實現累計垃圾進廠量1438.24萬噸 同比增長6.96%

中國金茂(00817.HK)1月簽約銷售金額67億元

寶勝國際(03813.HK):1月綜合經營收益淨額25.89億元 同比上升24.2%

中糧家佳康(01610.HK)運營快報:1月生豬出欄45萬頭

碧桂園(02007.HK):1月歸屬股東權益合同銷售金額約22.6億元

【醫藥創新】

石藥集團(01093.HK):SYH2059片獲美國臨牀試驗批准

復星醫藥(02196.HK):復宏漢霖擬於條件具備後於美國開展HLX99的I期臨牀試驗

石藥集團(01093.HK):恩益坦(注射用奧馬珠單抗)新適應症獲上市批准

【收購出售】

麗年國際(09918.HK)擬出售TTL 10%股權

【增發供股】

復興亞洲(00274.HK)擬按“10並1”基準進行股份合併

【增減持】

敏華控股(01999.HK)獲董事會主席黃敏利增持500萬股

【回購註銷】

友邦保險(01299.HK)2月10日耗資3.4億港元回購653萬股

匯豐控股(00005.HK)2月7日耗資1.66億港元回購203.48萬股

保誠(02378.HK)2月7日耗資467.92萬英鎊回購70萬股

中遠海控(01919.HK)2月10日耗資6191.48萬港元回購515.6萬股

時代電氣(03898.HK)2月10日耗資3150.97萬港元回購104.63萬股

泰格醫藥(03347.HK)2月10日耗資1938.41萬元回購37.43萬股A股

太古股份公司A(00019.HK)2月10日耗資1615萬港元回購25萬股

中國外運(00598.HK)2月10日耗資1342萬元回購258萬股A股

麗珠醫藥(01513.HK)2月10日耗資980萬元回購26.89萬股A股

亞洲金融(00662.HK)2月10日註銷10萬股已回購股份

Follow us
Find us on Facebook, Twitter , Instagram, and YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!
Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of this article is for reference only. It does not constitute an offer, solicitation, recommendation, opinion or guarantee of any securities, financial products or instruments.The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance.
uSMART
Wealth Growth Made Easy
Open Account